Understanding Diabetes and Its Growing Impact on Young People

Diabetes mellitus, encompassing both type 1 and type 2, is a chronic metabolic disorder that affects a rising number of adolescents and young adults worldwide. According to the Centers for Disease Control and Prevention, the prevalence of diagnosed diabetes among youth under 20 years increased by nearly 30% between 2001 and 2017. Type 2 diabetes, once considered an adult-onset condition, now accounts for a growing proportion of cases in young people, driven by rising rates of obesity and sedentary lifestyles. While the primary focus has traditionally been on blood glucose management, there is a growing recognition of the profound effects diabetes can have on reproductive health and long-term fertility. For young individuals navigating the transition to adulthood, understanding these impacts and adopting proactive management strategies is essential for preserving future family-building options. The intersection of diabetes and fertility involves complex biological, psychological, and social factors that require a coordinated care approach. This article explores the mechanisms behind diabetes-related fertility challenges, offers evidence-based strategies for preservation and preconception planning, and provides guidance for healthcare providers and patients alike.

How Diabetes Affects Fertility – Biological Mechanisms

Diabetes exerts its influence on fertility through multiple interconnected pathways, including hormonal disruption, oxidative stress, vascular damage, and metabolic imbalances. Chronically elevated blood glucose levels induce systemic inflammation and impair cellular function, which can directly compromise the reproductive organs and their regulatory systems. Additionally, insulin resistance—a hallmark of type 2 diabetes—disrupts the normal signaling of insulin-like growth factors and sex hormone binding globulin, further altering reproductive hormone balance.

Impact on Female Fertility

In adolescent and young adult women, diabetes can disrupt the delicate hormonal axis involving the hypothalamus, pituitary gland, and ovaries. Poor glycemic control is strongly linked to menstrual irregularities, anovulation, and reduced ovarian reserve. Women with type 1 diabetes often experience delayed menarche and a higher incidence of menstrual cycle abnormalities, with up to 40% reporting oligomenorrhea or amenorrhea. Research indicates that women with type 2 diabetes have a significantly increased risk of infertility compared to their nondiabetic peers, with some studies showing a two- to threefold higher likelihood of needing fertility treatment.

Furthermore, diabetes frequently coexists with polycystic ovary syndrome (PCOS), a common endocrine disorder characterized by hyperandrogenism, insulin resistance, and ovulatory dysfunction. The insulin resistance associated with type 2 diabetes can exacerbate PCOS symptoms, creating a vicious cycle that further impairs fertility. For young women with diabetes and PCOS, early intervention with metformin and lifestyle modifications can improve ovulation rates and metabolic health. A 2022 meta-analysis published in Human Reproduction Update found that metformin combined with lifestyle changes increased ovulation frequency by 50% compared to placebo in women with PCOS and prediabetes.

High blood sugar levels also increase the risk of pregnancy complications, such as preeclampsia, gestational diabetes, and preterm birth, making preconception planning a critical component of care. Even after conception, maternal hyperglycemia raises the risk of congenital anomalies and macrosomia, underscoring the need for optimal glycemic control before and during pregnancy. The risk of major congenital malformations in offspring of women with poorly controlled diabetes is two to three times higher than in women with HbA1c below 6.5%.

Specific Ovarian Effects

Chronic hyperglycemia damages ovarian tissue through the accumulation of advanced glycation end products (AGEs), which bind to receptors on granulosa cells and impair follicle development. Women with diabetes tend to have lower anti-Müllerian hormone (AMH) levels, indicating reduced ovarian reserve. A study in Fertility and Sterility (2021) reported that women with type 1 diabetes had AMH levels 25% lower than age-matched controls, suggesting that the disease accelerates ovarian aging.

Impact on Male Fertility

In adolescent and young adult males, diabetes can significantly affect reproductive function. Chronic hyperglycemia promotes oxidative stress in the testes, leading to damage to sperm DNA and impaired spermatogenesis. Studies consistently show that men with diabetes have lower sperm counts, reduced sperm motility, and higher percentages of abnormal sperm morphology compared to healthy controls. A systematic review in Andrology (2020) found that diabetic men had a 23% lower sperm concentration and 30% lower motility on average.

Erectile dysfunction (ED) is a well-known complication of diabetes, resulting from vascular and neurological damage. Young men with poorly controlled diabetes may experience ED earlier than their peers, affecting the ability to conceive naturally. Additionally, retrograde ejaculation—a condition where semen enters the bladder instead of exiting the urethra—occurs more frequently in men with diabetes due to autonomic neuropathy. Both ED and retrograde ejaculation can be managed with medical therapies, counseling, and assisted reproductive techniques, but glycemic control remains the cornerstone of prevention.

Of note, the negative effects of diabetes on male fertility may be partially reversible with improved blood glucose management. A study published in the Journal of Clinical Endocrinology & Metabolism found that men with type 1 diabetes who achieved tight glycemic control had sperm quality parameters comparable to nondiabetic men, highlighting the importance of early and consistent management. Even in type 2 diabetes, weight loss and improved insulin sensitivity have been shown to improve sperm quality.

The Critical Role of Glycemic Control in Fertility Preservation

Maintaining blood glucose levels within target ranges is the single most effective strategy for mitigating the fertility-related consequences of diabetes. The Hemoglobin A1c (HbA1c) test, which reflects average blood glucose over two to three months, is a key indicator of overall glycemic control. For adolescents and young adults planning a future pregnancy, an HbA1c level of less than 7% (ideally below 6.5% where safe) is recommended by the American Diabetes Association. Achieving this target often requires a combination of medication, diet, exercise, and monitoring tools.

Modern diabetes management tools, including continuous glucose monitors (CGMs) and insulin pumps, empower young people to achieve tighter control with greater flexibility. CGMs provide real-time data, allowing for immediate adjustments to diet, exercise, and medication. Hybrid closed-loop systems (also called artificial pancreas) further reduce HbA1c by automating insulin delivery based on CGM readings. For those with type 2 diabetes, oral medications like metformin, along with lifestyle modifications—balanced nutrition, regular physical activity, and weight management—can improve insulin sensitivity and support reproductive health. Even modest weight loss of 5-10% can restore ovulation in many women with type 2 diabetes.

It is important to recognize that diabetes management is a lifelong commitment, and the transition from pediatric to adult care often poses challenges. Young adults may struggle with adherence to treatment regimens as they assume greater responsibility for their health. Healthcare providers should offer age-appropriate education and support, emphasizing the connection between daily diabetes decisions and long-term fertility outcomes. Structured transition programs that include reproductive health counseling improve glycemic control and patient satisfaction.

Fertility Preservation Options for Adolescents and Young Adults

Advances in reproductive technology have expanded options for young people with diabetes who wish to preserve their fertility. Fertility preservation involves collecting and storing eggs, sperm, or embryos for future use. For adolescents who have not yet completed puberty, innovative techniques such as ovarian tissue cryopreservation are available in specialized centers. This method involves surgically removing a portion of ovarian cortex, freezing it, and later transplanting it back to restore hormone production and fertility.

Egg freezing (oocyte cryopreservation) is a viable option for young women with diabetes who may face reduced ovarian reserve due to the condition or who are not ready to conceive. The procedure requires ovarian stimulation and egg retrieval, which can be safely performed in women with well-controlled diabetes under the supervision of a reproductive endocrinologist and an endocrinologist. Glycemic targets may need adjustment during stimulation due to high estrogen levels affecting insulin sensitivity. For young men, sperm banking is a simple and effective method of fertility preservation and should be offered routinely, especially if there are concerns about declining sperm quality. Sperm banking is low-cost and noninvasive, with no special preparation needed beyond a semen sample.

Fertility preservation should be discussed early, ideally when diabetes is first diagnosed or during routine reproductive health visits. The cost can be a barrier, but many insurance plans now cover preservation for medical indications (such as chemotherapy), and some extend coverage to chronic conditions like diabetes that may affect fertility. Nonprofit organizations such as Livestrong Fertility and the Alliance for Fertility Preservation offer financial assistance and educational resources. Counseling about fertility preservation empowers young patients to take control of their reproductive futures and reduces anxiety about the potential impact of diabetes on their ability to become parents.

For young women with diabetes, planned pregnancies with optimized glycemic control are strongly associated with better maternal and fetal outcomes. Preconception care should begin at least three to six months before attempting conception and includes achieving target HbA1c levels, screening for diabetes complications (retinopathy, nephropathy, neuropathy), and managing coexisting conditions such as hypertension and thyroid disorders. Retinopathy can worsen during pregnancy due to hormonal and vascular changes, so an eye exam is essential before conception.

All women with diabetes should take a high-dose folic acid supplement (5 mg daily) beginning at least three months before conception to reduce the risk of neural tube defects. During pregnancy, frequent monitoring of blood glucose levels (ideally with a CGM), regular prenatal visits, and coordinated care between an obstetrician, endocrinologist, and dietitian are essential. The goal is to maintain blood glucose levels as close to normal as possible without causing hypoglycemia. Insulin requirements often increase significantly during the second and third trimesters, requiring dose adjustments every few weeks.

Adolescents and young adults may feel overwhelmed by the demands of pregnancy planning. Age-appropriate education, motivational interviewing, and peer support groups can help them navigate the physical and emotional challenges. Involving partners and family members in discussions about diabetes and pregnancy fosters a supportive environment that encourages adherence to care plans. Online communities like the Diabetes UK pregnancy forum provide real-world advice and connection.

Psychological and Social Considerations

The interplay between diabetes and fertility can have significant psychological and social consequences for young people. Fear of infertility, concerns about passing diabetes to offspring, and the daily burden of diabetes self-management can lead to anxiety, depression, and reduced quality of life. Young women with diabetes often report negative body image and worry about the impact of the condition on their relationships and future family. A 2023 survey in Diabetic Medicine found that 45% of young adults with diabetes expressed moderate to severe anxiety about their fertility, yet only 20% had discussed it with their healthcare team.

Healthcare providers should incorporate fertility-related discussions into routine diabetes care, normalizing these concerns and providing reliable information. Referral to a mental health professional specializing in chronic illness can be beneficial for those experiencing significant distress. Cognitive behavioral therapy (CBT) has shown efficacy in reducing diabetes distress and improving glycemic control. Peer mentorship programs, where young adults with diabetes share their experiences of managing fertility and having children, provide valuable emotional support and practical guidance. Organizations like the Juvenile Diabetes Research Foundation (JDRF) offer peer connections and resources.

Open communication with romantic partners is also important. Many young people fear that disclosing their diabetes may lead to rejection or stigmatization. Counseling that addresses communication skills and relationship dynamics can help patients feel more confident in discussing their health needs. Couples therapy can improve mutual understanding and problem-solving around diabetes management and family planning decisions.

When to Seek Help – Infertility Evaluation and Treatment

Adolescents and young adults with diabetes who have been trying to conceive for 12 months (or 6 months if the female partner is over 35) without success should be referred to a reproductive endocrinologist for a comprehensive fertility evaluation. For those with known risk factors, such as irregular periods, a history of PCOS, or severe obesity, earlier referral is appropriate. Women with diabetes who have been diagnosed with PCOS should see a reproductive specialist soon after diagnosis if they desire future fertility.

The evaluation typically includes an assessment of ovarian reserve (through AMH and antral follicle count), semen analysis for male partners, and imaging of the reproductive organs. In many cases, treatment options such as ovulation induction with clomiphene or letrozole, intrauterine insemination (IUI), or in vitro fertilization (IVF) can help achieve pregnancy. For individuals with diabetes, these procedures are generally safe when blood glucose is well-controlled, though close monitoring is required. Letrozole is preferred over clomiphene for women with PCOS and insulin resistance due to better pregnancy rates and lower multiple pregnancy risk.

Assisted reproductive technology (ART) has advanced dramatically, and live birth rates for women with diabetes who achieve good glycemic control approach those of nondiabetic women. A 2022 cohort study from the Society for Assisted Reproductive Technology found no difference in live birth rates per cycle between women with well-controlled diabetes (HbA1c <7%) and nondiabetic controls. The key is to manage diabetes proactively before and during treatment. Some fertility medications may affect blood sugar levels; for example, gonadotropins (used in IVF) can increase estrogen and cause insulin resistance, so coordination between the fertility specialist and the diabetes care team is essential to adjust insulin or oral agents accordingly. Intracytoplasmic sperm injection (ICSI) is often used for male factor infertility related to diabetes.

Conclusion

Diabetes in adolescents and young adults poses real challenges to fertility, but these are not insurmountable. Through comprehensive glycemic management, early counseling about fertility preservation, and careful preconception planning, young people with diabetes can maintain and even improve their reproductive potential. The integration of diabetes care and reproductive health services is critical to supporting patients in achieving their personal family-building goals. With the right medical guidance, emotional support, and technological resources, diabetes does not have to define or limit an individual's ability to become a parent. Empowering young individuals with knowledge and proactive strategies is the foundation for healthier futures – for themselves and for the families they may one day create. Healthcare providers must initiate these conversations early, and young patients should feel empowered to ask questions and advocate for their reproductive health. By breaking down barriers to care and fostering open dialogue, we can ensure that adolescents and young adults with diabetes have the same opportunities for parenthood as their peers.